MOST NOTEWORTHY: Infinity Pharmaceuticals, Legg Mason and Panera Bread were today's noteworthy upgrades:
- Rodman & Renshaw upgraded Infinity Pharmaceuticals (NASDAQ: INFI) to Outperform from Market Perform citing positive GSIT data at ASCO and expectations of a Phase III trial soon, encouraging data on its hedgehog inhibitor program, and valuation.
- Legg Mason (NYSE: LM) was upgraded to Neutral from Underperform at Credit Suisse citing valuation and potential M&A discussions.
- Piper upgraded shares of Panera Bread (NASDAQ: PNRA) to Buy from Neutral as they believe the company can lock in favorable wheat prices, creating upside to estimates and increased operating leverage.
OTHER UPGRADES: